Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

14
Number of overlapping holdings
28.6%
% of FTXH's 51 holdings also in PJP
58.3%
% of PJP's 24 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in PJP |
Overlap | |
---|---|---|---|---|
MERCK & CO. INC. | 7.3% | 6.0% | 6.0% | |
ABBVIE INC | 7.4% | 5.9% | 5.9% | |
JOHNSON & JOHNSON | 7.3% | 5.7% | 5.7% | |
PFIZER INC | 6.7% | 5.2% | 5.2% | |
ELI LILLY & CO | 4.2% | 6.7% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PJP
BRISTOL-MYERS SQUIBB CO | 6.3% | |
CARDINAL HEALTH INC | 4.7% | |
VERTEX PHARMACEUTICALS INC | 4.0% | |
ZOETIS INC | 3.7% | |
VIATRIS, INC. | 3.4% | |
CHARLES RIVER LABORATORIES | 2.2% | |
INCYTE CORP | 2.0% | |
MEDPACE HOLDINGS, INC. | 1.7% | |
JOHNSON & JOHNSON | 1.6% | |
PFIZER INC | 1.5% |
FTXH Underweight Relative to PJP
ABBOTT LABORATORIES | -6.1% | |
TARO PHARMACEUTICAL INDUS | -3.8% | |
LIGAND PHARMACEUTICALS-CL B | -3.4% | |
AMPHASTAR PHARMACEUTICALS INC | -3.4% | |
SUPERNUS PHARMACEUTICALS INC | -3.2% | |
GERON CORP | -3.2% | |
VALEANT PHARMACEUTICALS INT'L | -3.1% | |
BIOSANTE PHARMACEUTICALS INC | -3.1% | |
CORCEPT THERAPEUTICS INC | -3.0% | |
PRESTIGE BRANDS HOLDINGS INC | -2.8% |